Intracellular targets of cyclosporine
- 31 December 1990
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 23 (6), 1329-1334
- https://doi.org/10.1016/0190-9622(90)70361-k
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The effect of trifluoperazine, a calmodulin antagonist, on the growth of normal and malignant epidermal keratinocytes in cultureEuropean Journal of Cancer and Clinical Oncology, 1989
- The weak immunosuppressant cyclosporine D as well as the immunologically inactive cyclosporine H are potent inhibitors in vivo of phorbol ester TPA-induced biological effects in mouse skin and of Ca2+calmodulin dependent EF-2 phosphorylation in vitroBiochemical and Biophysical Research Communications, 1988
- Ciclosporin Inhibits Phorbol-Ester-Induced Hyperplastic Transformation and Tumor Promotion in Mouse Skin Probably by Suppression of Ca2+/Calmodulin-Dependent Processes such as Phosphorylation of Elongation Factor 2Skin Pharmacology and Physiology, 1988
- Calmodulin Activities Are Significantly Increased in Both Uninvolved and Involved Epidermis in PsoriasisJournal of Investigative Dermatology, 1985
- Increased Calmodulin Levels in Psoriasis and Low Ca++ Regulated Mouse Epidermal Keratinocyte CulturesJournal of Investigative Dermatology, 1985
- Biologically Active Calmodulin Levels Are Elevated in Both Involved and Uninvolved Epidermis in PsoriasisJournal of Investigative Dermatology, 1984
- Calmodulin levels are grossly elevated in the psoriatic lesionBritish Journal of Dermatology, 1983
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981
- Calmodulin stimulates DNA synthesis by rat liver cellsBiochemical and Biophysical Research Communications, 1980
- Cyclosporin a for PsoriasisNew England Journal of Medicine, 1979